Skip to main content

Nan Fung Group Holdings Ltd

Location
KAI TAK, K3
Portfolio Value
Small $131,488,711
Diversification
Diversified
Reports for
Pivotal bioVenture Partners Investment Advisor LLC Pivotal bioVenture Partners Fund I U.G.P. Ltd
Files via
Pivotal bioVenture Partners Investment Advisor LLC Pivotal bioVenture Partners Fund I U.G.P. Ltd
Filing Date
Global Rank
#7,788 / 8,795 ▼ 595 · as of Jun 2026
Top Industry
Biotechnology 98.0%
Period ended 3 months ago
Filed Aug 13, 2026 · 55d
21 quarters · since Jun 2021

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

25 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026
Top Position
26.5%
−0.8 pts
Top 5
66.2%
−2.1 pts
Top 10
82.4%
−1.0 pts
HHI
1,288
Sep 2023 → Jun 2026 · range 678 – 1,549
Diversified−39

Portfolio Trend

21 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026
Sector % Portfolio Value
Healthcare 97.2% $127,759,489
Technology 2.0% $2,596,621
Unclassified 0.9% $1,132,601

Last Quarter's Activity

Export CSV
Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased
1 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
2 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
25 tracked positions · $131,488,711 total · filing declares 25 positions · $131,488,918 · as of Jun 30, 2026
Ticker Company Shares Value (USD) % of Portfolio History

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.